Two Sigma Investments, LP Nektar Therapeutics Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,363,170 shares of NKTR stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,363,170
Previous 1,809,180 24.65%
Holding current value
$1.27 Million
Previous $2.24 Million 21.0%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.11 - $1.48 $495,071 - $660,094
-446,010 Reduced 24.65%
1,363,170 $1.77 Million
Q2 2024

Aug 14, 2024
SELL
$0.9 - $1.83 $245,484 - $499,150
-272,760 Reduced 13.1%
1,809,180 $2.24 Million
Q1 2024

May 15, 2024
SELL
$0.49 - $0.96 $46,570 - $91,239
-95,041 Reduced 4.37%
2,081,940 $1.94 Million
Q4 2023

Feb 14, 2024
SELL
$0.42 - $0.57 $259,588 - $352,298
-618,068 Reduced 22.11%
2,176,981 $1.22 Million
Q3 2023

Nov 14, 2023
SELL
$0.51 - $1.05 $207,460 - $427,125
-406,786 Reduced 12.7%
2,795,049 $1.68 Million
Q2 2023

Aug 14, 2023
BUY
$0.53 - $1.03 $622,954 - $1.21 Million
1,175,385 Added 58.0%
3,201,835 $1.86 Million
Q1 2023

May 15, 2023
BUY
$0.64 - $3.15 $1.04 Million - $5.13 Million
1,628,706 Added 409.49%
2,026,450 $1.42 Million
Q4 2022

Feb 14, 2023
SELL
$2.03 - $4.28 $901,382 - $1.9 Million
-444,031 Reduced 52.75%
397,744 $898,000
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $1.27 Million - $2.15 Million
418,355 Added 98.8%
841,775 $2.69 Million
Q2 2022

Aug 15, 2022
SELL
$3.17 - $6.17 $155,238 - $302,151
-48,971 Reduced 10.37%
423,420 $1.61 Million
Q1 2022

May 16, 2022
SELL
$4.16 - $13.72 $1.33 Million - $4.39 Million
-320,220 Reduced 40.4%
472,391 $2.55 Million
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $4.11 Million - $6.99 Million
379,857 Added 92.03%
792,611 $10.7 Million
Q3 2021

Nov 15, 2021
BUY
$13.07 - $18.84 $257,387 - $371,016
19,693 Added 5.01%
412,754 $7.41 Million
Q2 2021

Aug 16, 2021
BUY
$16.52 - $20.4 $4.99 Million - $6.16 Million
301,969 Added 331.5%
393,061 $6.75 Million
Q1 2021

May 17, 2021
BUY
$16.56 - $25.46 $924,213 - $1.42 Million
55,810 Added 158.18%
91,092 $1.82 Million
Q4 2020

Feb 16, 2021
SELL
$15.77 - $19.03 $2.98 Million - $3.6 Million
-188,945 Reduced 84.27%
35,282 $600,000
Q3 2020

Nov 16, 2020
SELL
$16.59 - $24.79 $938,247 - $1.4 Million
-56,555 Reduced 20.14%
224,227 $3.72 Million
Q2 2020

Aug 14, 2020
BUY
$16.86 - $23.44 $4.73 Million - $6.58 Million
280,782 New
280,782 $6.5 Million
Q1 2020

May 15, 2020
SELL
$14.47 - $27.96 $1.35 Million - $2.6 Million
-93,013 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$15.87 - $23.12 $1.48 Million - $2.15 Million
93,013 New
93,013 $2.01 Million
Q3 2019

Nov 14, 2019
SELL
$16.91 - $36.27 $1.18 Million - $2.54 Million
-69,932 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$31.0 - $36.3 $2.17 Million - $2.54 Million
69,932 New
69,932 $2.49 Million
Q1 2019

May 15, 2019
SELL
$31.58 - $46.35 $2.62 Million - $3.85 Million
-83,113 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$30.43 - $56.65 $1.37 Million - $2.56 Million
-45,102 Reduced 35.18%
83,113 $2.73 Million
Q3 2018

Nov 14, 2018
SELL
$46.46 - $68.49 $16.5 Million - $24.3 Million
-354,178 Reduced 73.42%
128,215 $7.82 Million
Q2 2018

Aug 14, 2018
BUY
$46.25 - $104.45 $22.3 Million - $50.4 Million
482,393 New
482,393 $23.6 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email